Biomade Technology

Biomade Technology is an independent research institute that converts scientific knowledge into applications which contribute to an improved quality of life. In this process we have developed a set of coherent  proprietary technologies centered on protein-based bio-nanotechnology. We are applying them to a variety of issues such as therapeutic peptides and proteins, artificial membrane systems and cell growth matrices for  tissue and organ engineering. 

Investors have recognized the power and validity of our method, resulting in the launch in 2007 of Mucosis B.V., a Biomade spin-out company focused on the development of mucosal vaccines

Given the current economic climate, we are to concentrating all of our resources on two of our most advanced technologies, therapeutic protein stabilization and cell growth matrices, which have been incorporated into two new Biomade spin-out companies, LanthioPep BV and Nano-FM BV, respectively.

This project is also financed by the European Union (European Regional Development Fund - ERDF)